Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.11
-0.05 (-0.97%)
Sep 23, 2026, 10:11 AM EDT - Market open
Taysha Gene Therapies Employees
Taysha Gene Therapies had 99 employees as of December 31, 2025. The number of employees increased by 26 or 35.62% compared to the previous year.
Employees
99
Change (1Y)
26
Growth (1Y)
35.62%
Revenue / Employee
$55,404
Profits / Employee
-$1,511,444
Market Cap
1.67B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 99 | 26 | 35.62% |
| Dec 31, 2024 | 73 | 21 | 40.38% |
| Dec 31, 2023 | 52 | -13 | -20.00% |
| Dec 31, 2022 | 65 | -113 | -63.48% |
| Dec 31, 2021 | 178 | 140 | 368.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Syndax Pharmaceuticals | 298 |
| Inhibrx Biosciences | 110 |
| AnaptysBio | 104 |
| Nanobiotix | 100 |
| Tyra Biosciences | 87 |
TSHA News
- 6 days ago - Taysha Gene Therapies initiated with an Outperform at Wolfe Research - TheFly
- 19 days ago - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Taysha Gene Therapies Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Taysha Gene Therapies Earnings release: Q2 2026 - Filings
- 6 weeks ago - Taysha Gene Therapies Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Taysha Gene Therapies reports Q2 EPS (13c), consensus (11c) - TheFly
- 6 weeks ago - Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11 - GlobeNewsWire